The results of the current study are consistent with those found by Souza et al (26), showing that defective P2X7 expression, as a result of miR-21 activation by a K-Ras mutation, may lead to reduced tumor-killing activity, resulting in a poorer prognosis. This evidence concerns the gene KRAS and neoplasm.